Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Astrazeneca Ord Shs AZNCF

Healthcare
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and... see more

Recent & Breaking News (OTCPK:AZNCF)

Benralizumab Phase III Trials Show Positive Results in Severe Asthma

Business Wire September 5, 2016

AstraZeneca Announces SYMBICORT Demonstrated Comparable Risk of Serious Asthma-Related Events and Lower Risk of Asthma Exacerbations Compared to Budesonide Alone

Business Wire August 31, 2016

The Market In 5 Minutes: Icahn, Netflix And A Quiet Market

Benzinga.com  August 29, 2016

Here Are All The Big Biotech Mergers In 2016

Benzinga.com  August 27, 2016

Drug Makers Stocks under Review -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline

PR Newswire August 25, 2016

Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?

Benzinga.com  August 24, 2016

The Market In 5 Minutes: Stocks Trading Higher As Earnings Season Quiets Down

Benzinga.com  August 24, 2016

Notice of Results

UK Regulatory news services, from the LSE August 24, 2016

AZ TO SELL ANTIBIOTICS BUSINESS TO PFIZER

UK Regulatory news services, from the LSE August 24, 2016

Appointment of Chairman

UK Regulatory news services, from the LSE August 24, 2016

Directorate Change

UK Regulatory news services, from the LSE August 24, 2016

Dividend Declaration

UK Regulatory news services, from the LSE August 24, 2016

GHG launches a new ambulatory cluster in Tbilisi

UK Regulatory news services, from the LSE August 24, 2016

Half-year Report

UK Regulatory news services, from the LSE August 24, 2016

Interim Results and Resource Update

UK Regulatory news services, from the LSE August 24, 2016

Pfizer Has Had A Busy M&A Year...Or Has It?

Benzinga.com  August 23, 2016

Director Declaration

UK Regulatory news services, from the LSE August 18, 2016

AstraZeneca completes agreement with LEO Pharma

UK Regulatory news services, from the LSE August 16, 2016

ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA

UK Regulatory news services, from the LSE August 10, 2016

Net Asset Value(s)

UK Regulatory news services, from the BW August 10, 2016